<DOC>
	<DOCNO>NCT00346047</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy safety BTDS compare placebo subject moderate severe low back pain .</brief_summary>
	<brief_title>Comparison BTDS ( Buprenorphine Transdermal System ) Placebo Low Back Pain</brief_title>
	<detailed_description>The primary objective study evaluate efficacy safety buprenorphine transdermal system ( BTDS ) compare placebo subject moderate severe low back pain sub-optimal response non-opioid analgesic treatment require opioid analgesic pain control .</detailed_description>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>Males female age 20 year old . Clinical diagnosis low back pain 4 week longer nonmalignant pain etiology . Subjects current chronic disease ( ) past history high possibility relapse , addition low back pain , require frequent analgesic therapy ( e.g . headache , fibromyalgia , gout , rheumatoid arthritis , osteoarthritis diabetic neuropathy ) .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>